Akhrot Dry Extract is a botanical ingredient associated with the common walnut, Juglans regia L., belonging to the Juglandaceae family. Akhrot is a widely recognized name for walnut in India and other South Asian regions. Botanical references associate this name with walnut kernels, leaves and bark, so the exact plant part used in a commercial extract should be confirmed before the ingredient is specified for a particular application.
Mediocon Inc. presents Akhrot Dry Extract for ingredient sourcing, product development and technical evaluation. Buyers and formulators should review the supplier’s product specification and Certificate of Analysis (CoA) to establish the botanical identity, plant part, extraction process, quality parameters and suitability for the intended use.
Kew’s Medicinal Plant Names Services associates Akhrot with Juglans regia and records different plant parts in medicinal references. This makes the plant-part declaration particularly important when comparing suppliers or preparing a technical product page.
Botanical dry extracts are generally prepared by extracting selected plant material, concentrating the extract and drying it to obtain a dry ingredient. The actual process for Akhrot Dry Extract depends on the plant part, extraction solvent, manufacturing method and any standardization requirements.
The extraction ratio, carrier ingredients, solvent residues, marker compounds and final powder characteristics should be documented by the manufacturer. These parameters should not be assumed from the common name alone.
Akhrot Dry Extract should be assessed against a defined product specification appropriate to its intended application. Relevant checks may include botanical identity, plant-part verification, appearance, moisture or loss on drying, identification testing, microbial quality and contaminant testing.
Depending on the raw material and extraction method, buyers may also require information about residual solvents, pesticide residues, heavy metals and other applicable quality parameters. Acceptance limits should be taken from the approved specification and current batch CoA.
Once the botanical identity, plant part and safety profile have been confirmed, Akhrot Dry Extract may be evaluated for suitable botanical ingredient and formulation-development projects. Potential areas of evaluation can include:
These are potential development areas rather than claims of proven efficacy or regulatory approval. Suitability depends on the exact extract, its composition, safety documentation and the regulations governing the finished product.
Store the product in its original, properly closed packaging and follow the supplier’s handling and storage instructions. Protect the material from conditions that may affect its quality, such as excessive moisture, heat, light or contamination, where relevant to the supplied product.
Packaging type, storage temperature, shelf life and transportation requirements must be confirmed from the current technical data sheet or product label.
Before placing an order, buyers should request the product’s botanical name, declared plant part, extraction solvent, extraction ratio, standardization details where applicable, current CoA, technical data sheet and relevant safety and regulatory documents. These records help confirm that the supplied material matches the intended specification.
Mediocon Inc. supports businesses evaluating botanical raw materials and ingredient sourcing requirements. For Akhrot Dry Extract, buyers should confirm the actual product identity and technical parameters with the supplier before approving it for a formulation or commercial application.
The botanical identity Juglans regia L. is used here as a provisional identification based on the common name Akhrot. Kernel, leaf and bark extracts are not interchangeable. Final product claims, specifications, plant-part details, extraction ratio, standardization, availability, origin and shelf life must be based on verified supplier documentation. Walnut-derived materials may also be relevant to allergen assessment depending on the source material and intended application. No therapeutic benefit is claimed by this description.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Akhrot Dry Extract Manufacturer in India | Mediocon Inc. and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Akhrot Dry Extract Manufacturer in India | Mediocon Inc. is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance